• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Syntax评分II在接受冠状动脉搭桥术的真实世界队列中的外部验证

External validation of SYNTAX score II in a real-world cohort undergoing coronary artery bypass grafting.

作者信息

Angleitner Philipp, Abfalterer Hannes, Kaider Alexandra, Manville Emely, Bichler Martin, Graber Michael, Pölzl Leo, Zimpfer Daniel, Sandner Sigrid, Bonaros Nikolaos

机构信息

Department of Cardiac Surgery, Medical University of Vienna, Spitalgasse 23, Vienna, 1090, Austria.

Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.

出版信息

J Cardiothorac Surg. 2025 Aug 7;20(1):324. doi: 10.1186/s13019-025-03572-x.

DOI:10.1186/s13019-025-03572-x
PMID:40775387
Abstract

BACKGROUND

Our aim was to evaluate SYNTAX Score II for its ability to predict mortality in all-comers undergoing isolated coronary artery bypass grafting.

METHODS

External validation of SYNTAX Score II was performed in a retrospective analysis of 2 tertiary care centers. Mortality at 4 years after surgery was defined as the primary outcome variable. External validation included assessment of calibration (calibration-in-the-large, observed-expected ratio, calibration slope) and discrimination (concordance statistic, Receiver Operating Characteristic curve). Additionally, SYNTAX Score II's performance was compared with the performance of EuroSCORE II, the logistic EuroSCORE, and ACEF Score.

RESULTS

The study cohort included 1454 patients (Medical University of Vienna, n = 782; Medical University of Innsbruck, n = 672). Kaplan-Meier survival curves showed that tertiles of SYNTAX Score II were significantly associated with mortality (log-rank test, p < 0.001). In a stratified multivariable Cox proportional-hazards regression model, the following score components were independently associated with mortality: age (hazard ratio 1.03, 95% confidence interval 1.00 to 1.06), creatinine clearance (hazard ratio 0.98, 95% confidence interval 0.97 to 0.99), left-ventricular ejection fraction (hazard ratio 0.97, 95% confidence interval 0.95 to 0.98), and chronic obstructive pulmonary disease (hazard ratio 2.02, 95% confidence interval 1.34 to 3.05). The anatomical SYNTAX Score was not independently associated with mortality (hazard ratio 1.00, 95% confidence interval 0.98 to 1.02). Assessment of SYNTAX Score II calibration revealed an observed-expected ratio of 0.61 and a calibration slope of 0.62 (p < 0.001 for comparison with slope = 1.0), indicating general overestimation of 4-year mortality. The c-statistic amounted to 0.73. Performance of SYNTAX Score II was comparable with the performance of EuroSCORE II (c-statistic 0.73), the logistic EuroSCORE (c-statistic 0.74) and ACEF Score (c-statistic 0.72).

CONCLUSIONS

Our analysis shows that SYNTAX Score II has acceptable discriminative strength with respect to 4-year mortality in all-comers undergoing isolated coronary artery bypass grafting. Notably, mortality is over-estimated in patients with higher SYNTAX Score II values. SYNTAX Score II, EuroSCORE II, the logistic EuroSCORE, and ACEF Score offer comparable predictive value towards 4-year mortality.

摘要

背景

我们的目的是评估SYNTAX评分II预测接受单纯冠状动脉搭桥术的所有患者死亡率的能力。

方法

在对2个三级医疗中心进行的回顾性分析中对SYNTAX评分II进行外部验证。将术后4年的死亡率定义为主要结局变量。外部验证包括校准评估(大样本校准、观察-期望比、校准斜率)和区分度评估(一致性统计量、受试者工作特征曲线)。此外,将SYNTAX评分II的性能与欧洲心脏手术风险评估系统II(EuroSCORE II)、逻辑欧洲心脏手术风险评估系统以及ACEF评分的性能进行比较。

结果

研究队列包括1454例患者(维也纳医科大学,n = 782;因斯布鲁克医科大学,n = 672)。Kaplan-Meier生存曲线显示,SYNTAX评分II的三分位数与死亡率显著相关(对数秩检验,p < 0.001)。在分层多变量Cox比例风险回归模型中,以下评分成分与死亡率独立相关:年龄(风险比1.03,95%置信区间1.00至1.06)、肌酐清除率(风险比0.98,95%置信区间0.97至0.99)、左心室射血分数(风险比0.97,95%置信区间0.95至0.98)以及慢性阻塞性肺疾病(风险比2.02,95%置信区间1.34至3.05)。解剖学SYNTAX评分与死亡率无独立相关性(风险比1.00,95%置信区间0.98至1.02)。SYNTAX评分II校准评估显示观察-期望比为0.61,校准斜率为0.62(与斜率 = 1.0比较,p < 0.001),表明对4年死亡率总体高估。c统计量为0.73。SYNTAX评分II的性能与EuroSCORE II(c统计量0.73)、逻辑欧洲心脏手术风险评估系统(c统计量0.74)以及ACEF评分(c统计量0.72)的性能相当。

结论

我们的分析表明,SYNTAX评分II对于接受单纯冠状动脉搭桥术的所有患者4年死亡率具有可接受的区分强度。值得注意的是,SYNTAX评分II值较高的患者死亡率被高估。SYNTAX评分II、EuroSCORE II、逻辑欧洲心脏手术风险评估系统以及ACEF评分对4年死亡率具有相当的预测价值。

相似文献

1
External validation of SYNTAX score II in a real-world cohort undergoing coronary artery bypass grafting.Syntax评分II在接受冠状动脉搭桥术的真实世界队列中的外部验证
J Cardiothorac Surg. 2025 Aug 7;20(1):324. doi: 10.1186/s13019-025-03572-x.
2
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
3
Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data.冠状动脉旁路移植术与经皮冠状动脉介入治疗支架置入治疗冠状动脉疾病的死亡率:一项个体患者数据的合并分析。
Lancet. 2018 Mar 10;391(10124):939-948. doi: 10.1016/S0140-6736(18)30423-9. Epub 2018 Feb 23.
4
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
5
Impact of prognostic nutritional index on mortality among patients receiving coronary artery bypass grafting surgery: a retrospective cohort study.预后营养指数对接受冠状动脉旁路移植术患者死亡率的影响:一项回顾性队列研究。
Heart. 2025 Feb 11. doi: 10.1136/heartjnl-2024-324471.
6
Ischemic Mitral Valve Regurgitation in Patients Undergoing Coronary Artery Bypass Grafting-Early and Late-Term Outcomes of Surgical Treatment.接受冠状动脉旁路移植术患者的缺血性二尖瓣反流——外科治疗的早期和晚期结果
J Clin Med. 2025 Jul 9;14(14):4855. doi: 10.3390/jcm14144855.
7
Does the Presence of Missing Data Affect the Performance of the SORG Machine-learning Algorithm for Patients With Spinal Metastasis? Development of an Internet Application Algorithm.缺失数据的存在是否会影响 SORG 机器学习算法在脊柱转移瘤患者中的性能?开发一种互联网应用算法。
Clin Orthop Relat Res. 2024 Jan 1;482(1):143-157. doi: 10.1097/CORR.0000000000002706. Epub 2023 Jun 12.
8
External Validation of the FREEDOM Score for Individualized Decision Making Between CABG and PCI.FREEDOM 评分用于个体化决策 CABG 与 PCI 选择的外部验证。
J Am Coll Cardiol. 2022 Apr 19;79(15):1458-1473. doi: 10.1016/j.jacc.2022.01.049.
9
Remote ischaemic preconditioning for coronary artery bypass grafting (with or without valve surgery).用于冠状动脉搭桥术(伴或不伴瓣膜手术)的远程缺血预处理
Cochrane Database Syst Rev. 2017 May 5;5(5):CD011719. doi: 10.1002/14651858.CD011719.pub3.
10
Left main coronary artery stenosis: a meta-analysis of drug-eluting stents versus coronary artery bypass grafting.左主干冠状动脉狭窄:药物洗脱支架与冠状动脉旁路移植术的荟萃分析。
JACC Cardiovasc Interv. 2013 Dec;6(12):1219-30. doi: 10.1016/j.jcin.2013.07.008.

本文引用的文献

1
2023 ESC Guidelines for the management of acute coronary syndromes.2023年欧洲心脏病学会急性冠状动脉综合征管理指南。
Eur Heart J. 2023 Oct 12;44(38):3720-3826. doi: 10.1093/eurheartj/ehad191.
2
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.2023 年 AHA/ACC/ACCP/ASPC/NLA/PCNA 慢性冠状动脉疾病患者管理指南:美国心脏协会/美国心脏病学会联合临床实践指南委员会的报告。
Circulation. 2023 Aug 29;148(9):e9-e119. doi: 10.1161/CIR.0000000000001168. Epub 2023 Jul 20.
3
Coronary atherosclerotic burden assessed by SYNTAX scores and outcomes in surgical, percutaneous or medical strategies: a retrospective cohort study.
SYNTAX 评分评估的冠状动脉粥样硬化负担与手术、经皮或药物治疗策略的结局:一项回顾性队列研究。
BMJ Open. 2022 Sep 22;12(9):e062378. doi: 10.1136/bmjopen-2022-062378.
4
Anatomical and clinical risk stratification tool for mortality risk assessment following revascularization for multivessel coronary artery disease.多支冠状动脉疾病血运重建后死亡率评估的解剖学和临床风险分层工具。
J Thorac Cardiovasc Surg. 2023 Sep;166(3):793-800.e5. doi: 10.1016/j.jtcvs.2021.11.090. Epub 2021 Dec 23.
5
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2021 ACC/AHA/SCAI 冠状动脉血运重建指南:美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
J Am Coll Cardiol. 2022 Jan 18;79(2):e21-e129. doi: 10.1016/j.jacc.2021.09.006. Epub 2021 Dec 9.
6
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2021 ACC/AHA/SCAI 冠状动脉血运重建指南:执行摘要:美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2022 Jan 18;145(3):e4-e17. doi: 10.1161/CIR.0000000000001039. Epub 2021 Dec 9.
7
External Validation of the SYNTAX Score II 2020.SYNTAX Score II 2020 外部验证
J Am Coll Cardiol. 2021 Sep 21;78(12):1227-1238. doi: 10.1016/j.jacc.2021.07.027.
8
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study.全球心血管疾病负担及危险因素, 1990-2019:来自 GBD 2019 研究的更新。
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021. doi: 10.1016/j.jacc.2020.11.010.
9
Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation.SYNTAX 评分 II 的再开发和验证:用于指导复杂冠状动脉疾病患者经皮与手术血运重建策略的个体化选择:多中心随机对照 SYNTAXES 试验的二次分析及外部队列验证。
Lancet. 2020 Oct 31;396(10260):1399-1412. doi: 10.1016/S0140-6736(20)32114-0. Epub 2020 Oct 8.
10
Comparison of clinical outcomes after coronary artery bypass grafting using stratified SYNTAX scores.使用分层SYNTAX评分比较冠状动脉旁路移植术后的临床结果。
Gen Thorac Cardiovasc Surg. 2020 Nov;68(11):1270-1277. doi: 10.1007/s11748-020-01361-y. Epub 2020 Apr 16.